𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Measurement of rigidity in Parkinson's disease

✍ Scribed by Dr. Arthur Prochazka; David J. Bennett; Marilee J. Stephens; Susan K. Patrick; Rosemary Sears-Duru; Ted Roberts; Jack H. Jhamandas


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
914 KB
Volume
12
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Clinical assessment of rigidity in parkinsonian patients is largely qualitative. The reliability and validity of the assessments are sometimes in doubt. Several β€œengineering” methods of quantifying rigidity have been described, but none has been adopted into general clinical practice. A possible reason is that these methods differ in crucial aspects from the clinical exam. We therefore tackled the problem by monitoring the clinical exam itself, using small sensors to measure the forces and displacements applied. Limb impedance(Z) was computed using parameter identification methods and compared to raters' verbalized ratings of rigidity based on a 5‐point scale: the Unified Parkinson's Disease Rating System. The qualitative and quantitative estimates of impedance covaried over a fourfold range, depending on the forces imposed and the subject's motor set. Raters differed by up to 1 full point in their mean qualitative ratings and sometimes disagreed on whether levodopa reduced rigidity. This was not due to any significant differences in the overall range of rigidity they evoked, but rather to the way they scored this range [the ratio of mean rating to mean impedance (R/Z) varied between raters and subjects]. On the other hand, the R/Z ratio was reproducible over separate sets of ratings and may therefore serve to convert measured impedance into a standardized rating. Our results indicate that the current clinical exam may be too abbreviated to detect the sometimes quite small reductions in rigidity after levodopa. We conclude that a device that conveniently quantifies the clinical assessment of rigidity is now available and will lead to more standardized protocols for rating rigidity in the near future.


πŸ“œ SIMILAR VOLUMES


Enhancement of rigidity in Parkinson's d
✍ Minna Hong; Joel S. Perlmutter; Gammon M. Earhart πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

## Abstract Rigidity, a cardinal symptom of Parkinson's disease (PD), increases with movement of a contralateral limb. It is unclear whether this effect is specific for movement of a contralateral limb. The goal of this study was to test the hypothesis that ipsilateral or contralateral movement wou

A novel method for systematic analysis o
✍ Takayuki Endo; Ryuhei Okuno; Masaru Yokoe; Kenzo Akazawa; Saburo Sakoda πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 1 views

## Abstract We propose a novel system that analyzes the components of rigidity in Parkinson's disease (PD) usually perceived by physicians, in a very simple and systematic way for routine clinical practice. Our system is composed of two compact force sensors, a gyroscope, and EMG surface electrodes

Depression in classic versus akinetic-ri
✍ Dr. Sergio E. Starkstein; Gustavo Petracca; ErΓ‘n Chemerinski; Alejandra TesΓ³n; L πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 488 KB

We examined the prevalence of major depression and dysthymia in 78 patients with the classic variant of Parkinson's disease (PD) (that is, tremor plus rigidity and/or bradykinesia), and in 34 patients with the akinetic-rigid variant. Although the prevalence of dysthymia was similar in both groups (c

A computer model of rigidity and related
✍ Philippe Le Cavorzin; Guy Carrault; Francis Chagneau; Pierre Rochcongar; HervΓ© A πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 193 KB πŸ‘ 1 views

## Abstract This work explores the involvement of spinal circuits in the generation of parkinsonian rigidity and related motor dysfunction. A computer model of spinal proprioceptive input processing, derived from previous work on spasticity modeling, was adapted to the simulation of parkinsonian ri

Clinical measures of progression in Park
✍ Werner Poewe πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 76 KB πŸ‘ 1 views

## Abstract Despite all recent advances in symptomatic therapy Parkinson's disease (PD) continues to be a relentlessly progressive neurodegenerative disorder. Therefore therapies that will slow or hold disease progression are a major medical unmet need in PD. Clinical measures of disease progressio

Visual symptoms in Parkinson's disease a
✍ Neil K. Archibald; Mike P. Clarke; Urs P. Mosimann; David J. Burn πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 132 KB

## Abstract Visual symptoms are common in PD and PD dementia and include difficulty reading, double vision, illusions, feelings of presence and passage, and complex visual hallucinations. Despite the established prognostic implications of complex visual hallucinations, the interaction between cogni